PROPER-GERD: A Prospective Crossover Study to Evaluate Probe Placement Optimization for Reflux Testing in Women and Lower-BMI Patients (NCT07716592)
🩺 Plain-English Summary (8th-Grade Level)
This is a prospective, within-subject controlled study involving simultaneous dual placement of wireless Bravo pH probes in each participant. Patients will receive pH testing when symptomatic for gastroesophageal reflux disease (GERD) to confirm diagnosis as part of standard of care. Each test is 96 hours with a symptom diary, GERD-HRQL, and RSI collected, which is also standard of care for patients presenting with GERD symptoms.
Who can join: Review the eligibility criteria below.
Location: The University o Chicago — Chicago, Illinois
Age range: 18 Years to 90 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- The University o Chicago — Chicago, Illinois
📞 Contact the Study Coordinator
Phone: (773) 702-6337
Email: yvigneswaran@bsd.uchicago.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in GERD
- Multicenter Single-Blind RCT of CTIF Versus LNF For Treatment of GERD in Patients Requiring Hiatal Hernia Repair — Irvine, California
- Long Term Outcomes of Bariatric Patients Treated With Surgery or Endoscopy — Baltimore, Maryland
- Antireflux Surgery Without Preoperative Esophageal Manometry — Cleveland, Ohio
- Mechanisms Preventing Pharyngeal Reflux — Milwaukee, Wisconsin
- Compassionate Use of Domperidone for Refractory Gastroparesis — Kansas City, Missouri
Explore by condition: All GERD clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.